WELLS FARGO & COMPANY/MN - TREACE MED CONCEPTS INC ownership

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 126 filers reported holding TREACE MED CONCEPTS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of TREACE MED CONCEPTS INC
ValueSharesWeighting
Q3 2023$138,259
-74.4%
10,546
-50.0%
0.00%
Q2 2023$539,508
-67.2%
21,091
-67.7%
0.00%
Q1 2023$1,646,922
+6671.0%
65,380
+6079.6%
0.00%
Q4 2022$24,323
-93.6%
1,058
-93.8%
0.00%
Q3 2022$379,000
+2607.1%
17,165
+1669.6%
0.00%
Q2 2022$14,000
-97.4%
970
-96.5%
0.00%
Q1 2022$531,000
-17.8%
28,115
-18.8%
0.00%
Q4 2021$646,000
-78.8%
34,638
-69.4%
0.00%
-100.0%
Q3 2021$3,048,000
+32.6%
113,327
+54.2%
0.00%0.0%
Q2 2021$2,298,00073,5130.00%
Other shareholders
TREACE MED CONCEPTS INC shareholders Q3 2023
NameSharesValueWeighting ↓
NEXT CENTURY GROWTH INVESTORS LLC 1,537,271$38,723,8564.26%
Millrace Asset Group, Inc. 72,595$1,8292.13%
Divisadero Street Capital Management, LP 175,000$4,408,2501.93%
Perceptive Advisors 2,442,250$61,520,2781.82%
SECTORAL ASSET MANAGEMENT INC 366,443$9,230,6991.77%
EMERALD MUTUAL FUND ADVISERS TRUST 1,120,875$28,234,8411.67%
EMERALD ADVISERS, LLC 1,363,453$34,345,3811.65%
FORMULA GROWTH LTD 124,900$3,146,2311.01%
Novo Holdings A/S 540,000$13,602,6000.90%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 755,379$19,027,9970.78%
View complete list of TREACE MED CONCEPTS INC shareholders